236 related articles for article (PubMed ID: 30552167)
1. Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study.
Aguilar-Salinas P; Agnoletto GJ; Brasiliense LBC; Santos R; Granja MF; Gonsales D; Aghaebrahim A; Sauvageau E; Hanel RA
J Neurointerv Surg; 2019 Apr; 11(4):347-351. PubMed ID: 30552167
[TBL] [Abstract][Full Text] [Related]
2. Cangrelor and Stenting in Acute Ischemic Stroke : Monocentric Case Series.
Elhorany M; Lenck S; Degos V; Sourour NA; Frasca Polara G; Shotar E; Godier A; Drir M; Mahtout J; Premat K; Alamowitch S; Samson Y; Clarençon F
Clin Neuroradiol; 2021 Jun; 31(2):439-448. PubMed ID: 32382875
[TBL] [Abstract][Full Text] [Related]
3. Intravenous cangrelor and oral ticagrelor as an alternative to clopidogrel in acute intervention.
Linfante I; Ravipati K; Starosciak AK; Reyes D; Dabus G
J Neurointerv Surg; 2021 Jan; 13(1):30-32. PubMed ID: 32414891
[TBL] [Abstract][Full Text] [Related]
4. Use of Cangrelor in Cervical and Intracranial Stenting for the Treatment of Acute Ischemic Stroke: A "Real Life" Single-Center Experience.
Cervo A; Ferrari F; Barchetti G; Quilici L; Piano M; Boccardi E; Pero G
AJNR Am J Neuroradiol; 2020 Nov; 41(11):2094-2099. PubMed ID: 33033047
[TBL] [Abstract][Full Text] [Related]
5. Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms.
Abdennour L; Sourour N; Drir M; Premat K; Shotar E; Taylor G; Godier A; Mathout J; Lenck S; Bernard R; Carpentier A; Degos V; Clarençon F
Clin Neuroradiol; 2020 Sep; 30(3):453-461. PubMed ID: 31309241
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.
Bowman S; Gass J; Weeks P
Ann Pharmacother; 2019 Feb; 53(2):171-177. PubMed ID: 30132336
[TBL] [Abstract][Full Text] [Related]
7. Cangrelor dose titration using platelet function testing during cerebrovascular stent placement.
Entezami P; Holden DN; Boulos AS; Paul AR; Field NC; Nourollahzadeh E; Yamamoto J; Dalfino JC
Interv Neuroradiol; 2021 Feb; 27(1):88-98. PubMed ID: 32611215
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet Therapy During Emergent Extracranial Internal Carotid Artery Stenting: Comparison of Three Intravenous Antiplatelet Perioperative Strategies.
Delvoye F; Maier B; Escalard S; Labreuche J; Thion LA; Aknouche S; Hebert S; Redjem H; Smajda S; Ciccio G; Allard J; Sabben C; Obadia M; Maertens de Noordhout A; Olivot JM; Blanc R; Piotin M; Desilles JP; Mazighi M
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105521. PubMed ID: 33310073
[TBL] [Abstract][Full Text] [Related]
9. Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention.
Sawlani NN; Harrington RA; Stone GW; Steg PG; Gibson CM; Hamm CW; Price MJ; Prats J; Deliargyris EN; Mahaffey KW; White HD; Bhatt DL
Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28039321
[TBL] [Abstract][Full Text] [Related]
10. Randomized Comparison of Oral P2Y
Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C
JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204
[TBL] [Abstract][Full Text] [Related]
11. Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke.
Cohen JE; Gomori JM; Leker RR; Eichel R; Arkadir D; Itshayek E
Neurol Res; 2011 May; 33(4):439-43. PubMed ID: 21535945
[TBL] [Abstract][Full Text] [Related]
12. A Safety Evaluation of Cangrelor in Patients Undergoing PCI.
Franchi F; Rollini F; Park Y; Angiolillo DJ
Expert Opin Drug Saf; 2016; 15(2):275-85. PubMed ID: 26680584
[TBL] [Abstract][Full Text] [Related]
13. The safety of triple antiplatelet therapy under thromboelastography guidance in patients undergoing stenting for ischemic cerebrovascular disease.
Wu Z; Liu AF; Zhou J; Zhang Y; Wang K; Li C; Qiu H; Jiang WJ
J Neurointerv Surg; 2019 Apr; 11(4):352-356. PubMed ID: 30100558
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low dose intravenous cangrelor in a consecutive cohort of patients undergoing neuroendovascular procedures.
Cagnazzo F; Radu RA; Derraz I; Lefevre PH; Dargazanli C; Machi P; Morganti R; Gascou G; Fendeleur J; Rapido F; Costalat V
J Neurointerv Surg; 2023 Dec; 16(1):88-93. PubMed ID: 36922032
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
[TBL] [Abstract][Full Text] [Related]
16. Stenting of the cervical internal carotid artery in acute stroke management: The Karolinska experience.
Mpotsaris A; Kabbasch C; Borggrefe J; Gontu V; Soderman M
Interv Neuroradiol; 2017 Apr; 23(2):159-165. PubMed ID: 28304205
[TBL] [Abstract][Full Text] [Related]
17. Management of acute ischemic stroke due to tandem occlusion: should endovascular recanalization of the extracranial or intracranial occlusive lesion be done first?
Rangel-Castilla L; Rajah GB; Shakir HJ; Shallwani H; Gandhi S; Davies JM; Snyder KV; Levy EI; Siddiqui AH
Neurosurg Focus; 2017 Apr; 42(4):E16. PubMed ID: 28366065
[TBL] [Abstract][Full Text] [Related]
18. What is the Role of Cangrelor in Patients Undergoing PCI?
Droppa M; Geisler T
Curr Vasc Pharmacol; 2018; 16(5):484-489. PubMed ID: 29345586
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.
Leonardi S; Mahaffey KW; White HD; Gibson CM; Stone GW; Steg GW; Hamm CW; Price MJ; Todd M; Dietrich M; Gallup D; Liu T; Skerjanec S; Harrington RA; Bhatt DL
Am Heart J; 2012 May; 163(5):768-776.e2. PubMed ID: 22607853
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
Firstenberg MS; Dyke CM; Angiolillo DJ; Ramaiahm C; Price M; Brtko M; Welsby I; Chandna H; Holmes DR; Voeltz M; Tummala P; Hutyra M; Manoukian SV; Prats J; Todd M; Liu T; Chronos N; Dietrich M; Montalescot G; Cannon LA; Topo EJ
Heart Surg Forum; 2013 Apr; 16(2):E60-9. PubMed ID: 23625478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
